Essential Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65K Sell
16
-1
-6% -$59 ﹤0.01% 2054
2026
Q1
$649 Buy
17
+6
+55% +$190 ﹤0.01% 2355
2025
Q4
$240 Sell
11
-23
-68% -$478 ﹤0.01% 2396
2025
Q3
$730 Buy
34
+31
+1,033% +$695 ﹤0.01% 2107
2025
Q2
$77 Buy
+3
New +$88 ﹤0.01% 2100

Other funds holding ATEX

Essential Partners's ATEX Position: Q2 2026 in Review

Essential Partners reduced its Anterix (ATEX) stake by 5.9% in Q2 2026, selling an estimated $59 and leaving 16 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

Essential Partners first reported a position in ATEX in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Essential Partners held 16 shares of Anterix worth $1.65K as of Q2 2026.
  • Essential Partners sold 1 Anterix share in Q2 2026, an estimated $59.
  • Anterix made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2054 holding.
  • Essential Partners first reported a position in Anterix in Q2 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.